Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced MalignanciesNeil L. Spector, Sarah Bacus|Journal of Clinical Oncology|2005Cited by 364
Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in TumorNeil L. Spector, Kevin M. Koch|PLoS ONE|2015Cited by 31